Suppr超能文献

刺突依赖性 SARS-CoV-2 致病性与 TMPRSS2 相关。

Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.

机构信息

PsiMega2 (Pvt.) Ltd., Islamabad, Pakistan.

School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.

出版信息

J Med Virol. 2021 Jul;93(7):4205-4218. doi: 10.1002/jmv.26911. Epub 2021 Mar 18.

Abstract

Epidemiological data shows a discrepancy in COVID-19 susceptibility and outcomes with some regions being more heavily affected than others. However, the factors that determine host susceptibility and pathogenicity remain elusive. An increasing number of publications highlight the role of Transmembrane Serine Protease 2 (TMPRSS2) in the susceptibility of the host cell to SARS-CoV-2. Cleavage of viral spike protein via the host cell's TMPRSS2 enzyme activity mediates viral entry into the host cell. The enzyme synthesis is regulated by the TMPRSS2 gene, which has also been implicated in the entry mechanisms of previously reported Coronavirus infections. In this review, we have investigated the pathogenicity of SARS-CoV-2 and disease susceptibility dependence on the TMPRSS2 gene as expressed in various population groups. We further discuss how the differential expression of this gene in various ethnic groups can affect the SARS-CoV-2 infection and Coronavirus disease (COVID)-19 outcomes. Moreover, promising new TMPRSS2 protease blockers and inhibitors are discussed for COVID-19 treatment.

摘要

流行病学数据显示,COVID-19 在不同地区的易感性和结果存在差异,有些地区比其他地区受到的影响更严重。然而,决定宿主易感性和致病性的因素仍然难以确定。越来越多的出版物强调了跨膜丝氨酸蛋白酶 2(TMPRSS2)在宿主细胞对 SARS-CoV-2 的易感性中的作用。通过宿主细胞的 TMPRSS2 酶活性切割病毒刺突蛋白,介导病毒进入宿主细胞。该酶的合成受 TMPRSS2 基因调控,该基因也与先前报道的冠状病毒感染的进入机制有关。在这篇综述中,我们研究了 SARS-CoV-2 的致病性以及宿主对 TMPRSS2 基因的易感性依赖性,该基因在不同人群中表达。我们进一步讨论了该基因在不同种族群体中的差异表达如何影响 SARS-CoV-2 感染和冠状病毒病(COVID-19)的结果。此外,还讨论了有前途的新型 TMPRSS2 蛋白酶阻滞剂和抑制剂在 COVID-19 治疗中的应用。

相似文献

1
Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.刺突依赖性 SARS-CoV-2 致病性与 TMPRSS2 相关。
J Med Virol. 2021 Jul;93(7):4205-4218. doi: 10.1002/jmv.26911. Epub 2021 Mar 18.
7

引用本文的文献

9
Small molecules in the treatment of COVID-19.小分子药物治疗 COVID-19。
Signal Transduct Target Ther. 2022 Dec 5;7(1):387. doi: 10.1038/s41392-022-01249-8.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验